Research Focus

Former Employee. SKI Surgery; NE Executive Consultant

Recent additions – View all

1. Effect of zileuton and celecoxib on urinary LTE4 and PGE-M levels in smokers

   Journal Article

   Mohebati, A.; Milne, G. L.; Zhou, X. K.; Duffield-Lillico, A. J.; Boyle, J. O.; Knutson, A.; Bosworth, B. P.; Kingsley, P. J.; Marnett, L. J.; Brown, P. H.; more...
   Cancer Prevention Research (2013)

   Fulltext@MSK | Save
2. Elevated levels of urinary prostaglandin E metabolite indicate a poor prognosis in ever smoker head and neck squamous cell carcinoma patients

   Journal Article

   Kekatpure, V. D.; Boyle, J. O.; Zhou, X. K.; Duffield-Lillico, A. J.; Gross, N. D.; Lee, N. Y.; Subbaramaiah, K.; Morrow, J. D.; Milne, G.; Lippman, S. M.; more...
   Cancer Prevention Research (2009)

   Fulltext@MSK | Save
3. Levels of prostaglandin E metabolite and leukotriene E(4) are increased in the urine of smokers: Evidence that celecoxib shunts arachidonic acid into the 5-lipoxygenase pathway

   Journal Article

   Duffield-Lillico, A. J.; Boyle, J. O.; Xi, K. Z.; Ghosh, A.; Butala, G. S.; Subbaramaiah, K.; Newman, R. A.; Morrow, J. D.; Milne, G. L.; Dannenberg, A. J.
   Cancer Prevention Research (2009)

   Fulltext@MSK | Save